A recent study presented at the XII National Congress of Penitentiary Health Society held in Cartgena states that if all prisoners were treated with hepatitis C would reduce deaths by 88%, save costs (up to € 4,000 / person per year) and this way, cases of contagion per year would be reduced.
Also, in this same congress it was affirmed that the diagnosed cases of HIV in the penitentiaries have been reduced in the last years.
The conclusion of this congress was that “the difference in cost-effectiveness analysis is minimal between prisoners and non-prisoners, that is, treating prisoners and treating non-prisoners produces, practically, the same benefits from the individual point of view. epidemiological difference is another, since the vast majority of cases diagnosed are not by risk practices but by the use of parenteral drugs.
